Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,578,665
-$3,104,658 QoQ
Shares Held
461,275
-5.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#241
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGAR LOMAX CO/VA holds $161,967,278 across 7 Drug Manufacturers - General names. BMY ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
1,365,777 | $32,887,910 | |
| 2 | JNJ |
Johnson & Johnson
|
125,880 | $31,969,743 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
461,275 | $26,578,665 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
147,640 | $18,652,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
143,985 | $18,502,072 | |
| 6 | AMGN |
Amgen Inc
|
46,233 | $16,741,893 | |
| 7 | ABBV |
AbbVie Inc.
|
66,103 | $16,634,158 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,578,665 | 461,275 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $29,683,323 | 489,420 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,517,427 | 65,210 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,010,425 | 66,750 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,008,251 | 86,590 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,364,680 | 87,960 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,063,136 | 195,600 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,316,438 | 199,390 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,412,524 | 202,565 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,127,724 | 205,195 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,965,403 | 116,262 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,054,587 | 121,547 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,059,106 | 126,022 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,855,392 | 127,765 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,045,404 | 153,515 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,973,452 | 154,360 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,008,920 | 155,960 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $11,078,651 | 151,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,355,617 | 150,050 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,968,101 | 151,565 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,324,692 | 154,515 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $10,125,420 | 160,390 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,025,522 | 177,745 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,903,145 | 180,845 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,198,566 | 173,445 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $9,475,800 | 170,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||